KPTIQ — Karyopharm Therapeutics Share News
0.000.00%
Last trade - 00:00- $0.39m
- $257.57m
- $146.07m
Karyopharm Therapeutics Inc expected to post a loss of 33 cents a share - Earnings Preview
Karyopharm Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Karyopharm Therapeutics Q4 Net Income USD -41.837 Million
Karyopharm Therapeutics Inc expected to post a loss of 31 cents a share - Earnings Preview
Karyopharm Therapeutics Inc expected to post a loss of 31 cents a share - Earnings Preview
Karyopharm Therapeutics rises on job cuts
Brief: Karyopharm Reports Prelim Unaudited 2023 Revenue And 2024 Objectives
Brief: Karyopharm Announces New Preliminary Data In Overall Survival In Selinexor-Treated Patients With Advanced Or Recurrent TP53 Wild-Type Endometrial Cancer
Karyopharm Therapeutics Inc reports results for the quarter ended in September - Earnings Summary
Brief: Karyopharm Therapeutics Q3 Net Income USD -34.506 Million
Karyopharm Therapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-SeaStar, SJW Group, Pinterest
U.S. STOCKS ON THE MOVE-Crypto, Miromatrix Medical, US banks
U.S. STOCKS ON THE MOVE-JinkoSolar, Reviva, MeiraGTx
Karyopharm rises on Bristol Myers collaboration for blood cancer therapy
Brief: Karyopharm Announces Clinical Trial Collaboration With Bristol Myers Squibb
Brief: Karyopharm Therapeutics Board Increased Size Of Board To Nine Members
Brief: Karyopharm Therapeutics Q2 Net Income USD -32.63 Million
Karyopharm Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview